For research use only. Not for therapeutic Use.
QC-01-175 targets ZFP91, ZN653, ZN827 also degraded at 4 h, 1 µM in patient iPSC derived FTD neurons harboring MAPT A152T mutation.
| Catalog Number | I035298 |
| CAS Number | 2267290-96-8 |
| Synonyms | QC-01-175; QC 01-175; QC01-175; QC-01175; QC 01175; QC01175; |
| Molecular Formula | C33H34N6O7 |
| Purity | 98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | N-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethyl)-3-(5H-pyrido[4,3-b]indol-7-yl)propanamide |
| InChI | InChI=1S/C33H34N6O7/c40-28(8-5-20-4-6-21-23-19-34-11-10-24(23)37-26(21)18-20)36-13-15-46-17-16-45-14-12-35-25-3-1-2-22-30(25)33(44)39(32(22)43)27-7-9-29(41)38-31(27)42/h1-4,6,10-11,18-19,27,35,37H,5,7-9,12-17H2,(H,36,40)(H,38,41,42) |
| InChIKey | NWTCZTAQSRLSCP-UHFFFAOYSA-N |
| SMILES | O=C(NCCOCCOCCNC1=CC=CC2=C1C(N(C2=O)C3CCC(NC3=O)=O)=O)CCC4=CC5=C(C6=C(C=CN=C6)N5)C=C4 |
